The journey to diagnosis can be long and expensive, especially with such a complex disease. Exagen strives to decrease the time to diagnosis with innovative biomarkers that provide more in-depth diagnostic information for autoimmune diseases, allowing your doctor to reach an accurate diagnosis quicker. #lupusawarenessmonth #LAM
Exagen Inc.
Biotechnology Research
Vista, California 6,423 followers
A patient focused, discovery driven life science company.
About us
Exagen Inc. is a Patient Focused, Discovery Driven, CLIA-certified, CAP-accredited laboratory with a growing menu of proprietary, internally developed tests focusing in the area of Rheumatology and Autoimmune diseases. Committed to Personalized Medicine, our AVISE tests are specifically designed to provide objective information to physicians and patients for more accurate, efficient diagnosis and better disease management. For more information on our company, please visit www.Exagen.com. For more information on AVISE testing services, please visit www.AviseTest.com. Read our Social Media Terms of Use here: http://bit.ly/smtou
- Website
-
http://www.Exagen.com
External link for Exagen Inc.
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Vista, California
- Type
- Public Company
- Founded
- 2002
- Specialties
- Diagnostic Testing, Prognostic Testing, Therapeutic Drug Monitoring, and Biotech
Locations
-
Primary
1261 Liberty Way
Vista, California 92081, US
Employees at Exagen Inc.
Updates
-
Diagnosing an autoimmune disease is notoriously difficult and complex. It often takes years of evaluating vague symptoms, many of which can exist in several autoimmune conditions. AVISE testing aims to change that through advanced diagnostic analysis. #lupusawarenessmonth #LAM
-
-
Lupus predominantly affects women between the ages of 15 and 44, although it can occur in men and children, as well. Exagen is continuously innovating diagnostic tools to provide more accurate and comprehensive information about autoimmune diseases. #lupusawarenessmonth
-
-
Highlights from Exagen’s first quarter 2024 earnings report. Read more here: https://shorturl.at/pTY49
-
-
Exagen announces strong first quarter 2024 results & raises guidance for full year. Read more here: https://shorturl.at/fqJR6
-
-
Today is #WorldLupusDay, a time to raise global awareness of lupus and support those affected by it. The journey to diagnosis can be long and financially, emotionally and physically draining. Exagen’s mission is to #makelupusvisible by making early diagnosis possible.
-
-
Exagen is honored to be sponsoring the first week of lupus awareness month, focused on diagnosis. Our AVISE diagnostic tests are designed to help rheumatologists differentially diagnose autoimmune connective tissue diseases, including Lupus. #lupusawarenessmonth #LAM
-
-
Lupus Awareness Month is a vital platform to educate, advocate, and unite in support of those affected by Lupus and other autoimmune connective tissue diseases. #lupusawarenessmonth #LAM
-
-
Exagen announces strong financial results for the fourth quarter and full-year 2023. Read more here: https://shorturl.at/oqHYZ
-
-
Exagen provides a financial update in advance of the JPMorgan Healthcare Conference. Read more here: https://shorturl.at/ouDWX
-